Variant report
| Variant | esv3386659 |
|---|---|
| Chromosome Location | chr1:242208979-242215777 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:11)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:11 , 50 per page) page:
1
| No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
|---|---|---|---|---|---|---|
| 1 | FOXA1 | chr1:242214317-242214536 | HepG2 | liver: | n/a | n/a |
| 2 | FOXA2 | chr1:242214054-242214789 | A549 | lung: | n/a | n/a |
| 3 | FOXA2 | chr1:242214220-242214667 | A549 | lung: | n/a | n/a |
| 4 | HEY1 | chr1:242214694-242214927 | K562 | blood: | n/a | n/a |
| 5 | JUND | chr1:242214967-242214987 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 6 | POLR2A | chr1:242215526-242215627 | MCF10A-Er-Src | breast: | n/a | n/a |
| 7 | POLR2A | chr1:242214356-242214565 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 8 | POLR2A | chr1:242214386-242214545 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 9 | POLR2A | chr1:242214365-242214547 | H1-hESC | embryonic stem cell: | n/a | n/a |
| 10 | YY1 | chr1:242214812-242214939 | K562 | blood: | n/a | chr1:242214867-242214879 |
| 11 | YY1 | chr1:242214788-242214953 | H1-hESC | embryonic stem cell: | n/a | chr1:242214867-242214879 |
| No data |
| No data |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| TUBB8P6 | TF binding region |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs376529991 | chr1:242214407-242214408 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs370038168 | chr1:242214427-242214428 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs373355814 | chr1:242214444-242214445 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs145372137 | chr1:242214451-242214452 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs61484511 | chr1:242214462-242214463 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs149209778 | chr1:242214486-242214487 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs112113704 | chr1:242214497-242214498 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs560623174 | chr1:242214503-242214504 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs369633176 | chr1:242214517-242214518 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs373501887 | chr1:242214521-242214522 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs557849131 | chr1:242214527-242214528 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs544303003 | chr1:242214538-242214539 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs552369792 | chr1:242214563-242214564 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs570981967 | chr1:242214585-242214586 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs568066569 | chr1:242214596-242214597 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs530548070 | chr1:242214605-242214606 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs12727414 | chr1:242214644-242214645 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs192172082 | chr1:242214677-242214678 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs529831888 | chr1:242214719-242214720 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs12407849 | chr1:242214724-242214725 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs553192267 | chr1:242214749-242214750 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs566669306 | chr1:242214753-242214754 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs113914950 | chr1:242214760-242214761 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs12408998 | chr1:242214781-242214782 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs200267150 | chr1:242214782-242214783 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs566554436 | chr1:242214789-242214790 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs12401590 | chr1:242214821-242214822 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs12408999 | chr1:242214828-242214829 | Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 29 | rs374644020 | chr1:242214842-242214843 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs554661266 | chr1:242214852-242214853 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs574726742 | chr1:242214854-242214855 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs540275441 | chr1:242214866-242214867 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs560801799 | chr1:242214870-242214871 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs149034611 | chr1:242214883-242214884 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs545965483 | chr1:242214924-242214925 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs200563454 | chr1:242214957-242214958 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs143010922 | chr1:242214962-242214963 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs201707359 | chr1:242214965-242214966 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs114412235 | chr1:242214987-242214988 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs185575254 | chr1:242214988-242214989 | Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs151172674 | chr1:242215007-242215008 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs140306105 | chr1:242215021-242215022 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs529657807 | chr1:242215028-242215029 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs80325536 | chr1:242215054-242215055 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs546301146 | chr1:242215072-242215073 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs556950154 | chr1:242215091-242215092 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs373308375 | chr1:242215111-242215112 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs538971989 | chr1:242215117-242215118 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs552393104 | chr1:242215129-242215130 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs569118867 | chr1:242215158-242215159 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Esophageal squamous carcinoma | 21637470 | CNVD |
| HIV/AIDS | 22032296 | CNVD |
| Schizophrenia | 19415332 | CNVD |
| Melanoma | 18172304 | CNVD |
| Rett syndrome | 21593744 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Cancer | 20164919 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Non-small cell lung cancer | 21044232 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 20632083 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Gastrointestinal stromal cancer | 20470368 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Hepatocellular carcinoma | 22174799 | CNVD |
| Medulloblastoma | 21292688 | CNVD |
| Phyllodes tumor | 17334353 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Multiple myeloma | 21628407 | CNVD |
| Cancer | 16751803 | CNVD |
| Prostate cancer | 16705090 | CNVD |
| Neuroblastoma | 19435921 | CNVD |
| Breast cancer | 17850661 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Intracranial tumor | 16823260 | CNVD |
| Medulloblastoma | 18056178 | CNVD |
| Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Neuroblastoma | 21899760 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Ewing''s sarcoma | 22429812 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Breast cancer | 17001317 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Testicular germ cell tumor | 18059402 | CNVD |
| Ependymoma | 18628472 | CNVD |
| Leukemia | 18628472 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Acute lymphoblastic leukemia | 19100363 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Urothelial carcinoma | 21177765 | CNVD |
| Acute lymphoblastic leukemia | 20067559 | CNVD |
| Chordoma | 18071362 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Hepatocellular carcinoma | 18803288 | CNVD |
| Urothelial tumor | 18831757 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Medulloblastoma | 16783165 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Congenital abnormalities | 21549014 | CNVD |
| Developmental delay | 21549014 | CNVD |
| Mental retardation | 21549014 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Cancer | 20164920 | CNVD |
| Cancer | 17060936 | CNVD |
| abnormal development | 18461090 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Arrhythmogenic right ventricular cardiomyopathy | 17576883 | CNVD |
| Multiple myeloma | 16616336 | CNVD |
| Developmental delay | 21147756 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Glioblastoma multiforme | 22291905 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Disease | 21936942 | CNVD |
| laryngomalacia | 21936942 | CNVD |
| GLUT3 deficiency syndrome | 20509907 | CNVD |
| Developmental delay | 21373258 | CNVD |
| Acute lymphoblastic leukemia | 17443227 | CNVD |
| Developmental delay | 19490664 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr1:242214400-242214800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
| 2 | chr1:242214400-242215000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
| 3 | chr1:242214800-242215000 | Flanking Active TSS | HUES6 Cell Line | embryonic stem cell |
| 4 | chr1:242214800-242215200 | Active TSS | K562 | blood |
| 5 | chr1:242215000-242215200 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
| 6 | chr1:242215000-242215200 | Enhancers | H9 Cell Line | embryonic stem cell |
| 7 | chr1:242215000-242215200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
| 8 | chr1:242215000-242215200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
| 9 | chr1:242215000-242215400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
| 10 | chr1:242215000-242215800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
| 11 | chr1:242215000-242216400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
| 12 | chr1:242215200-242216200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
| 13 | chr1:242215200-242216400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
| 14 | chr1:242215200-242216400 | Weak transcription | H9 Cell Line | embryonic stem cell |
| 15 | chr1:242215200-242216600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
| 16 | chr1:242215400-242216400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |






